Omnipaque 140 and Renal failure acute - a phase IV clinical study of FDA data
Renal failure acute is found among people who take Omnipaque 140, especially for people who are female, 60+ old, have been taking the drug for < 1 month.
The phase IV clinical study analyzes which people take Omnipaque 140 and have Renal failure acute. It is created by eHealthMe based on reports of 1,105 people who have side effects when taking Omnipaque 140 from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
1,105 people reported to have side effects when taking Omnipaque 140.
Among them, 89 people (8.05%) have Renal failure acute.
What is Omnipaque 140?
Omnipaque 140 has active ingredients of iohexol. eHealthMe is studying from 1,106 Omnipaque 140 users for its effectiveness, alternative drugs and more.
What is Renal failure acute?
Renal failure acute (rapid kidney dysfunction) is found to be associated with 3,077 drugs and 3,071 conditions by eHealthMe.
Number of Omnipaque 140 and Renal failure acute reports submitted per year:
Time on Omnipaque 140 when people have Renal failure acute *:
Gender of people who have Renal failure acute when taking Omnipaque 140*:
Age of people who have Renal failure acute when taking Omnipaque 140 *:
Common drugs people take besides Omnipaque 140 *:
Common side effects people have besides Renal failure acute *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Omnipaque 140 and have Renal failure acute?Check whether Renal failure acute is associated with a drug or a condition
How to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Alokaily FA, Alghamdi M, Almalki AS, Alhussaini H, "Aspirin induced leukocytoclastic vasculitis, lower gastrointestinal hemorrhage and acute renal failure (mimicking systemic vasculitis)", Saudi medical journal, 2013 Apr .
How severe was Renal failure acute and when was it recovered:
Expand to all the drugs that have ingredients of iohexol:
Alternative drugs to, pros and cons of Omnipaque 140:
- Omnipaque 140 (1,106 reports)
Common Omnipaque 140 side effects:
- Pain: 188 reports
- Acute kidney failure: 164 reports
- Stress and anxiety: 157 reports
Browse all side effects of Omnipaque 140:a b c d e f g h i j k l m n o p q r s t u v w x y z
Renal failure acute treatments and more:
- Renal failure acute (73,864 reports)
COVID vaccines that are related to Renal failure acute:
- Renal failure acute in Moderna COVID Vaccine
- Renal failure acute in Pfizer BioNTech Covid Vaccine
- Renal failure acute in Johnson and Johnson Covid Vaccine
Common drugs associated with Renal failure acute:
- Metformin: 5,929 reports
- Aspirin: 5,823 reports
- Lasix: 5,489 reports
- Furosemide: 5,462 reports
- Lisinopril: 4,178 reports
- Simvastatin: 3,559 reports
- Omeprazole: 3,429 reports
- Prednisone: 3,314 reports
- Allopurinol: 3,241 reports
- Lopurin: 3,241 reports
All the drugs that are associated with Renal failure acute:
- Renal failure acute (3,077 drugs)
Common conditions associated with Renal failure acute:
- High blood pressure: 6,913 reports
- Type 2 diabetes: 3,046 reports
- Diabetes: 2,594 reports
- Pain: 2,373 reports
- Atrial fibrillation/flutter: 2,264 reports
- Multiple myeloma: 1,881 reports
All the conditions that are associated with Renal failure acute:
- Renal failure acute (3,071 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on iohexol (the active ingredients of Omnipaque 140) and Omnipaque 140 (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Skelaxin and Drug Administration Error - now
- Flexeril and Venous Injury - now
- Doxil and Mallory-Weiss Syndrome - now
- Allegra-D 12 Hour and Pain Exacerbated - a second ago
- Prednisone and Pulmonary Vascular Disorder - a second ago
- Everolimus and Lung Infiltration - a second ago
- Magnesium and Cryptococcal Fungaemia - a second ago
- Protonix and Upper Airway Obstruction - 2 seconds ago
- Bisoprolol Fumarate and Haemolytic Uraemic Syndrome - 2 seconds ago
- Methotrexate and Hepaplastin Decreased - 3 seconds ago